Algo version: 0.98b
Biohit Oyj is listed at the HEL Exchange
Biohit Oyj [BIOBV.HE]
HEL Sector: Healthcare Industry:Biotechnology

Is Biohit Oyj stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Biohit Oyj pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Tuesday 15th of April 2014 were paid €0.7234 per share. Over the last 3 times between 2012 and 2014, Biohit Oyj has paid €1.7604 with an average of €0.59 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Biohit Oyj 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was €2.45, you would have made a loss of €-0.310 per share or -12.65%

No, the average daily trading liquidity for Biohit Oyj is €12 027 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Biohit Oyj has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 1.93, the company's ability to pay off the debt is good. Biohit Oyj has a good net profit margin of 14.39% and should have high tolerances against inflation.

We have calculated the inflation risk for Biohit Oyj to be low [0.1 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.